BIIB Biogen
$222.89 -0.31%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-0.31%
YTD
+46.40%
P/E
39.24
P/B
1.41
ROE
4.5%
Div yield
—
Beta
0.31
Market cap
$32.7B
RSI (14)
53
Next earnings
Oct 28, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$224.53
Close
$222.89
VWAP (n/a)
—
Day high
$225.97
Day low
$218.00
Volume
1.0M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?
Yahoo Finance · Oct 6
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
Yahoo Finance · Oct 2
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Yahoo Finance · Sep 29
Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs?
Yahoo Finance · Sep 28
Biogen (NASDAQ:BIIB) Q2 Earnings: Leading The Therapeutics Pack
Yahoo Finance · Sep 25
How Investors May Respond To Biogen (BIIB) Advancing At-Home LEQEMBI Pen And Kidney Disease Data
Yahoo Finance · Sep 23
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Jul 29, 2026 View → 8-K Jul 29, 2026 View → 8-K Jul 1, 2026 View → 8-K Jun 10, 2026 View → 8-K May 14, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell BIIB. Try it in the Lab to size a position and see the risk.